Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -21.56% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -13.86%. Over the past 30 days, the price of TXG has fallen by 20.17%. And in the last five days, it has surged by 6.30%.
The current stock price for 10x Genomics Inc (TXG) is $12.99. The stock experienced a significant increase during the last trading session, reaching $18.0 after opening at $12.99. It dipped to a low of $9.0 before ultimately closing at $11.54.
In terms of market performance, 10x Genomics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $24.76 on 09/03/24, while the lowest value was $6.78 on 04/07/25.
52-week price history of TXG Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. 10x Genomics Inc’s current trading price is -47.54% away from its 52-week high, while its distance from the 52-week low is 91.59%. The stock’s price range for this period has been between $6.78 and $24.76. The Healthcare sector company’s shares saw a trading volume of about 3.77 million for the day, which was lower than the average daily volume of 3.87 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
10x Genomics Inc (TXG) has experienced a quarterly rise of 69.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.62B and boasts a workforce of 1306 employees.
Expert Opinions: Analysts’ Ratings for 10x Genomics Inc
As of right now, 5 analysts are rating 10x Genomics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 9 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.88, with a change in price of +1.34. Similarly, 10x Genomics Inc recorded 3,729,550 in trading volume during the last 100 days, posting a change of +11.50%.
TXG’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TXG stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.
TXG Stock Stochastic Average
As of today, the raw stochastic average of 10x Genomics Inc over the past 50 days is 97.04%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 94.02%. Additionally, the Stochastic %K and %D values for the company were 65.55% and 64.91%, respectively, over the past 20 days.
